Ilona Kurnatowska

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 205 citations · Full text

Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3–5

Ilona Kurnatowska, Piotr Grzelak, Anna Masajtis‐Zagajewska et al. · Polskie Archiwum Medycyny Wewnętrznej · 2015 · 113 citations · Full text

Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease

Ilona Kurnatowska, Piotr Grzelak, Anna Masajtis‐Zagajewska et al. · Kidney & Blood Pressure Research · 2016 · 58 citations · Full text

Perfusion of kidney graft pyramids and cortex in contrast-enhanced ultrasonography in the determination of the cause of delayed graft function.

Piotr Grzelak, Konrad Szymczyk, Janusz Strzelczyk et al. · PubMed · 2011 · 49 citations

Serum Osteoprotegerin Is a Predictor of Progression of Atherosclerosis and Coronary Calcification in Hemodialysis Patients

Ilona Kurnatowska, Piotr Grzelak, Magdalena Kaczmarska et al. · Nephron Clinical Practice · 2010 · 37 citations